Found: 19
Select item for more details and to access through your institution.
A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 6, p. 1306, doi. 10.1007/s10637-022-01311-w
- By:
- Publication type:
- Article
Comparison of Design, Eligibility, and Outcomes of Neuroendocrine Neoplasm Trials Initiated From 2000 to 2009 vs 2010 to 2020.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 10, p. e2131744, doi. 10.1001/jamanetworkopen.2021.31744
- By:
- Publication type:
- Article
Advances in the treatment of gastroenteropancreatic neuroendocrine tumors.
- Published in:
- Clinical & Experimental Gastroenterology, 2010, v. 3, p. 79
- By:
- Publication type:
- Article
Modern Management of Gastric Neuroendocrine Neoplasms.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 9, p. 1137, doi. 10.1007/s11864-024-01207-2
- By:
- Publication type:
- Article
Patient Selection and Toxicities of PRRT for Metastatic Neuroendocrine Tumors and Research Opportunities.
- Published in:
- Current Treatment Options in Oncology, 2020, v. 21, n. 4, p. 1, doi. 10.1007/s11864-020-0711-9
- By:
- Publication type:
- Article
Patient Selection and Toxicities of PRRT for Metastatic Neuroendocrine Tumors and Research Opportunities.
- Published in:
- 2020
- By:
- Publication type:
- journal article
State of the Art: Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.217851
- By:
- Publication type:
- Article
Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 7, p. 882, doi. 10.2967/jnumed.118.217851
- By:
- Publication type:
- Article
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 66, doi. 10.2967/jnumed.117.202275
- By:
- Publication type:
- Article
PAM staining intensity of primary neuroendocrine neoplasms is a potential prognostic biomarker.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-68071-6
- By:
- Publication type:
- Article
Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 6, p. e2112539, doi. 10.1001/jamanetworkopen.2021.12539
- By:
- Publication type:
- Article
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 950, doi. 10.1002/onco.13923
- By:
- Publication type:
- Article
Surgery Versus Surveillance for Well‐Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11‐Year Analysis of the National Cancer Database.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e276, doi. 10.1634/theoncologist.2019-0466
- By:
- Publication type:
- Article
Correction to: PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 2, p. 671, doi. 10.1007/s12325-022-02360-6
- By:
- Publication type:
- Article
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 10, p. 2372, doi. 10.1007/s00259-020-04709-x
- By:
- Publication type:
- Article
Prognostic value of somatostatin receptor expressing tumor volume calculated from <sup>68</sup>Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 11, p. 2244, doi. 10.1007/s00259-019-04455-9
- By:
- Publication type:
- Article
The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 10, p. 1132, doi. 10.1093/jnci/djad121
- By:
- Publication type:
- Article